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The aim of the present work was to establish whether apoptotic HEp-2 cells 
demonstrated an altered susceptibility to adherence by the pathogenic yeast Candida 
albicans. Cultures of HEp-2 cells were treated with concentrations of three chemo- 
therapeutic agents ufficient o induce cell death by apoptosis and this was confirmed 
by microscopic examination and by the loss of membrane asymmetry (as indicated by 
phosphatidylserine externalization) and the fragmentation of nuclear DNA into 
distinct subunits. Cells in the early stages of apoptosis demonstrated a reduced 
susceptibility to adherence by a number of strains of C. albicans. A correlation 
between the decrease in yeast adherence and the loss of membrane asymmetry, 
associated with the early stages of apoptosis, was established. 
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Introduction 
The ability of C. albicans to adhere to a range of host tissues 
is critical to the success of the pathogenic process since 
adherence is a necessary prerequisite to colonisation and 
infection [1,2]. Adherence also facilitates the persistence of 
the yeast in environments which may be hostile to its 
presence [3]. Adherence to host tissue is accomplished by a 
combination of specific and non-specific mechanisms. The 
former are the dominant contributors to the process and 
include a range of ligand-receptor interactions [3,4]. Non- 
specific mechanisms include electrostatic nteractions, cell 
surface hydrophobicity and aggregation [5,6]. While it is 
clear that these latter forces contribute to the process of 
yeast adherence, it is generally accepted that their overall 
contribution is less than that of the specific mechanisms [7]. 
The aim of the work presented in this paper was to 
establish whether HEp-2 cells in the early stages of apop- 
tosis displayed altered susceptibility to yeast adherence. 
Apoptosis is a form of cell death biochemically and mor- 
phologically distinct from necrosis. It may occur as part of 
the normal developmental processes involved in tissue for- 
mation or as a result of a variety of cellular stimuli or 
Correspondence: Dr K. Kavanagh, Department of Biology, 
Maynooth College, Maynooth, County Kildare, Ireland. Tel. + 353- 
1-708 3859; Fax. + 353-1-708 3845; E-mail kkavanagh@may.ie. 
© 1997 ISHAM 
insults [8]. Apoptosis may be the dominant mode of cell 
death in vertebrates and has the advantage, when compared 
with necrosis, of not inducing an immune response. This 
form of cell death is characterized by the fragmentation f
nuclear DNA into distinct nucleosome sized subunits, due 
to the activation of an endogenous endonuclease, and mem- 
brane blebbing which results in the formation of apoptotic 
bodies [9]. These are recognized and engulfed by phago- 
cytes without he release of intracellular components which 
would evoke an immune response [10]. 
One of the earliest stages in the apoptotic process is 
the loss of membrane asymmetry as a result of the down- 
regulation of the ATP-dependent amino-phospholipid 
translocase and activation of a non-specific lipid scram- 
blase [11]. This process occurs without concomitant 
membrane rupture in lymphocytes [12] or adherent cell 
lines [13] and before cell shrinkage or chromatin conden- 
sation [14]. One consequence of the loss of membrane 
asymmetry is the appearance of phosphatidyl serine (PS) 
on the outer leaflet of the lipid bilayer [15]. Flow cyto- 
metric detection of the binding of FITC-Annexin V to PS 
has been employed to measure the increased PS levels in 
the outer leaflet of the cell membrane of cells undergoing 
apoptosis [12]. Externalization of PS during the early 
stages of apoptosis has been demonstrated in a range of 
human and murine cell types [14]. 
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In this study, apoptosis was induced in HEp-2 cells by 
exposure to a number of anticancer drugs and confirmed 
by the loss of membrane asymmetry and DNA cleavage. 
Three cancer chemotherapeutic agents were chosen for 
this work. 
Doxorubicin is a widely used anticancer drug effective 
against a range of tumours. Its principal mode of action 
lies in the ability to interact with cellular DNA although 
other mechanisms, including interference with the action 
of DNA topoisomerase II, have been demonstrated [16]. 
Methotrexate acts as an inhibitor of DNA synthesis by 
blocking dihydrofolate reductase [17]. Cisplatin kills cells 
by covalently interacting with and crosslinking DNA. 
Cells treated with this drug proceed to G2 and undergo 
aberrant mitosis which leads to unequal chromosome 
distribution [18]. The three anticancer drugs employed in 
this study have previously been shown to kill cells by 
inducing apoptosis [16-18]. 
Materials and methods 
Yeast strain and culture conditions 
Candida albicans ATCC 44990, ATCC 10231 and strain 
MEN (serotype B, originally isolated from an eye 
infection) were used in this study. Cultures were grown 
overnight to the stationary phase (1-2 x 10S/ml) in 
YEPD (2% (w:v) glucose, 2% (w:v) Bactopeptone and 1% 
(w:v) yeast extract) at 37 °C and 200 rev min l in an 
orbital incubator. 
Cancer cell line 
The HEp-2 cell line (ATCC CCL23, obtained from the 
American Type Culture Collection, MD), derived from an 
epidermoid carcinoma of the larynx [19], was cultured in 
MEM (Sigma) supplemented with 5% (v:v) fetal calf 
serum (Gibco), 4 ms  L-glutamine (Gibco) and 1% (v:v) 
Penn-Strep (Sigma). The adherent cells were grown 
in 80 cm 2 tissue culture flasks (Nunc) at 37 °C and 
subcultured by trypsinization every 3~, days. 
Anticancer drugs 
Doxorubicin and cisplatin were obtained from Farmitalia 
Carlo Erba (Milan, Italy). Methotrexate was purchased 
from Lederle (Hampshire, England). 
Toxicity assay 
Subconftuent HEp-2 cells were harvested by trypsin- 
ization, washed and resuspended in PBS. Cells were enu- 
merated using a haemocytometer and diluted with MEM 
to give a cell density of 2 x 104/ml. Ninety-six well plates 
(Nunc) were seeded with 100 ¢tl of this cell suspension per 
well and incubated at 37 °C in a humidified atmosphere 
with 5% CO2 for 24 hours to allow cell attachment. 
Subsequently, a range of concentrations of chemothera- 
peutic agent was added to the wells and plates were further 
incubated until the controls reached 80 90% confluence 
(typically 5-6 days). At the end of this period the medium 
plus the drug was decanted from the wells, the cells at- 
tached to the base of each well were washed with PBS and 
finally fixed with 10% formalin for 10 min. Cell growth 
was quantified using the crystal violet dye elution (CVDE) 
method [20]. Stained plates were read in a Titertek Multi- 
scan MCC 340 plate reader at 570 nm and the results are 
expressed as a percentage of the growth attained by the 
controls. The CVDE method stains cells adhering to the 
base of the well so allowing the quantification of the extent 
of cell growth. All toxicity assays were performed in 
triplicate and a representative example is presented. 
DNA gel electrophoresis 
HEp-2 cells were harvested by trypsinization, washed and 
resuspended in PBS. Cells (1 x 106) were resuspended in
lysis buffer (20 mN EDTA (Sigma), 0'8% (w:v) sodium 
lauryl sarcosinate, 100 mM Tris (pH 8.0)) (Merck) and 
10 ¢tl (10 mg ml- l )  RNase A (Boehringer Mannheim) and 
incubated at 37 °C for 18 hours. Proteinase K (1 mg ml-  1) 
(Boehringer Mannheim) was subsequently added and 
the samples incubated for a further 2 h at 50 °C. Prior to 
loading onto the gel 5¢tl loading buffer (0'25% (w:v) 
bromophenol blue (Sigma), 50% (w:v) glycerol (Merck)) 
was added to the samples. Agarose gels (0.8% (w:v), 
BioRad) were prepared using 1 x TBE. Samples were 
loaded onto the gels and run at 55 v for 3"5 h. Lambda 
c1857 Sam 7 DNA digested with HindIII (BioRad) was 
used as DNA size standard. DNA was visualized under 
UV illumination following ethidium bromide staining. 
FITC-Annexin V staining 
FITC-Annexin V probe was obtained from Bendar 
Medsystems (BioWhittaker, UK). HEp-2 cells, previously 
exposed to the chemotherapeutic drugs for various 
periods, were resuspended in 95 pl of the binding buffer 
(10 mM Hepes/NaOH (pH 7.4), 150 mM NaC1, 5 mM KC1, 
1 mM MgC12, 1'8 mM CaC12), and 10pl of the undiluted 
probe was added [12]. Cells were incubated in the dark for 
10 rain at room temperature. Samples were subsequently 
diluted in 1 ml of binding buffer and analysed by flow 
cytometry on a FACScan (Becton Dickinson) using 
Lysis II software. 
Adherence assay 
The strains of C. albicans were grown to the stationary 
phase in YEPD at 37 °C and 200 rev min-  1 in an orbital 
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incubator, harvested by centrifugation, washed twice with 
PBS and resuspended in PBS. HEp-2 cells for use in 
adherence assays were harvested using a cell scraper 
(Nunc), washed twice with PBS and resuspended in PBS. 
Yeast cells (5 x 10 7) and HEp-2 cells (1 x 105) were 
mixed in a final volume of 2 ml and incubated at 37 °C for 
2 h. The mixture was subsequently smeared onto glass 
slides and allowed to air dry. This was heat fixed and 
stained with a 1'0% (w:v) crystal violet solution. The 
number of yeast cells adhering to each of 200 HEp-2 cells 
was enumerated microscopically per treatment. All adher- 
ence assays were performed in triplicate and results from 
representative assays are presented. The values for adher- 
ence represent the mean number of yeast cells adhering per 
HEp-2 cell + SE of the mean. A Sigma-Stat package was 
used throughout this study for all statistical analyses. A 
Dunns t-test was performed to establish whether a signifi- 
cant difference xisted between treatments and controls. 
Results 
Measurement of relative toxicity of chemotherapeutic 
agents to HEp-2 cells 
Assays to determine the relative toxicity of each of the 
three anticancer drugs to HEp-2 cells were performed so 
that levels sufficient o induce apoptosis rather than necro- 
sis could be established. Ninety-six well plates were seeded 
with HEp-2 cells at a density of 2 x 103 per well. Cells 
were exposed to a range of concentrations of each chemo- 
therapeutic agent and growth was quantified using the 
CVDE method as described. A representative sample of 
the results of such an assay using doxorubicin is presented 
(Fig. 1). The results from this assay allowed the identifica- 
tion of doxorubicin concentrations (15 ng ml - l  and 62 ng 
ml-1) which induced cell death by apoptosis. In the case 
of methotrexate apoptosis was seen upon exposure to drug 
concentrations of 125 ng ml 1 and 250 mgml  ] while 
cisplatin induced HEp-2 cell death by apoptosis at 400 ng 
ml -  1 and 800 ng ml -  l (data not presented). In all cases 
the occurrence of apoptosis at the stated drug concen- 
trations was confirmed by microscopic examination. 
Induction of apoptosis in HEp-2 cells 
HEp-2 cells were induced to die by apoptosis by exposure 
to the three chemotherapeutic agents at the previously 
established concentrations. Cells were exposed to the rel- 
evant concentrations of each drug, initially for 24 h, 
trypsinized and stained using FITC-Annexin V as de- 
scribed• Annexin V binding to PS has been used as a 
measure of the loss of membrane asymmetry associated 
with the onset ofapoptosis [12]. The cells were analysed by 
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Fig. 1 Toxicity of doxorubicin to HEp-2 cells• HEp-2 cells were 
plated at a density of 2 x 104/ml in 96-well plates (Nunc). After 
24 h incubation doxorubicin was added over the above 
concentration range• The extent of cell growth was determined 
after 5 6 days incubation using the CVDE method as described 
[20]. Growth is expressed as a percentage of that attained by the 
controls• The standard error is shown when greater than 2.5% of 
the mean. 
flow cytometry on a FACScan and a representative s t of 
results for doxorubicin treated cells is presented (Fig. 2). 
This figure shows the relative levels of fluorescence due to 
FITC-Annexin V binding to doxorubicin-treated and un- 
treated HEp-2 cells. Cells which had been treated with 
doxorubicin demonstrate increased fluorescence as a result 
of the elevated levels of PS present on the outer leaflet of 
the plasma membrane, concomitant with the loss of mem- 
brane asymmetry. PS externalization, indicative of the loss 
of membrane asymmetry, was also evident when HEp-2 
cells were treated with methotrexate orcisplatin for 24 h at 
the concentrations e tablished previously. 
Cultures of HEp-2 cells were exposed to doxorubicin 
(15 and 62 ng ml a) in a similar manner to that described 
above for periods of 24, 48 and 72 h. DNA was isolated 
from these cultures and separated by electrophoresis as 
described. The characteristic DNA fragmentation pattern, 
associated with the apoptotic-induced cleavage of nuclear 
DNA into nucleosome sized units, was only observed in 
cultures which had been exposed to drug for 72 h and not 
in those treated for 24 or 48 h (data not presented). 
These results (detection of the loss of membrane 
asymmetry in apoptotic cells after 24h and DNA 
fragmentation after 72 h exposure to chemotherapeutic 
drug) are consistent with the sequence of events in the 
apoptotic pathway in that the loss of membrane asym- 
metry is an early event [14,15] while the cleavage of 
DNA into discrete subunits occurs at a later stage in the 
process [8]. 
D
ow
nloaded from
 https://academ
ic.oup.com
/m
m
y/article-abstract/35/3/219/931667 by M
aynooth U
niversity user on 03 O
ctober 2019
222 Cotter et al. 
Table 1 Mean number of C. albicans adhering per HEp-2 cell 
which had previously been exposed to doxorubicin 
Doxorubicin concentration 
C. albicans 
strain Control 15 ng ml-  1 62 ng ml 1 
z 
v,~/[ Control 
I I 
\~1  Treatment A 
I I 
~.  Treatment B
Log Annexin V binding 
Fig. 2 FITC-Annexin V fluorescence of doxorubicin treated 
HEp-2 cells. Cultures of HEp-2 cells were exposed to 15 ng ml-  1 
(Treatment A) or 62 ng ml-  1 (Treatment B) doxorubicin for 24 h. 
Cells were harvested, stained with FITC-Annexin V and analysed 
by flow cytometry using a Becton-Dickinson FACScan with Lysis 
II software. Ten thousand cells were analysed from each treatment. 
Adherence of C. albicans to HEp-2 cells in the early 
stages of apoptosis 
Subconfluent cultures of HEp-2 cells were exposed to each 
of the three anticancer drugs for 24 h and the induction of 
apoptosis was confirmed by the increased FITC-Annexin 
V fluorescence associated with PS externalization. Adher- 
ence assays were subsequently performed as described 
using three stains of C. albicans and HEp-2 cells in the 
early stages of apoptosis-as verified by the loss of 
membrane asymmetry. 
The results of the series of adherence assays (Table 1) 
indicate that the overall susceptibility of HEp-2 cells to 
adherence by C. albicans decreased following treatment 
with concentrations of doxorubicin which had been 
shown to induce apoptosis: as indicated by the loss of 
membrane asymmetry. In the adherence assays which 
used C. albicans ATCC 44990 there is an almost 50% 
reduction (P < 0.05) in yeast adherence to HEp-2 cells 
treated with 62 ng ml -  1 doxorubicin for 24 h. In the case 
of strains MEN and ATCC 10231 there is a 75% reduc- 
ATCC 44990 1.24 :k 0.06 0-83 4- 0"08 0.70 i 0.07 
MEN 1.13 + 0.07 0-42 -4- 0.06 0.30 + 0.04 
ATCC 10231 0.96 4- 0.07 0-69 + 0.05 0.46 4- 0-04 
HEp-2 cells were treated for 24 h with doxorubicin (15 and 62 ng 
ml- l )  and the induction of apoptosis was confirmed by the loss 
of membrane asymmetry as indicated by PS externalization. Adher- 
ence assays were performed as described. All values represent the 
mean number of yeast cells adhering per HEp-2 cell + SE of the 
mean with 200 HEp-2 cells being enumerated per assay. 
tion (P < 0"05) and a 50% reduction (P < 0.05), respect- 
ively, in adherence to HEp-2 cells treated with this 
concentration of doxorubicin. HEp-2 cells exposed to 
15 ng ml-  1 doxorubicin also demonstrate a lower amount 
of adherence by the three C. albicans strains employed 
here (Table 1). These data demonstrate hat treatment of 
HEp-2 cells with doxorubicin concentrations sufficient o 
induce apoptosis results in a decrease in the susceptibility 
of HEp-2 cells to adherence by the three strains of 
C. albicans used in this study. 
The reduction in adherence was not exclusively a 
feature of doxorubicin-induced membrane alterations 
associated with onset of apoptosis. Cultures of HEp-2 
cells were exposed to methotrexate (125 and 250 ng ml- l )  
and cisplatin (400 and 800 ng ml- l )  for periods of 24 h. 
Cells were subsequently harvested and stained with FITC- 
Annexin V to confirm the loss of membrane asymmetry. 
Adherence assays were conducted using HEp-2 cells 
treated with drug in a similar manner and cells of 
C. albicans ATCC 44990. The results from this series of 
assays indicated that treatment of HEp-2 cells with 250 ng 
m1-1 methotrexate or 800 ng m1-1 cisplatin for 24h 
resulted in a reduction of 35% (P < 0.05) in the suscepti- 
bility of the HEp-2 cells to adherence by C. albicans (data 
not presented). The loss of membrane asymmetry, con- 
comitant with the onset of apoptosis in HEp-2 cells, is 
sufficient o reduce the susceptibility of the HEp-2 cells to 
yeast adherence. 
PS externalization in confluent cultures 
By varying the cell density at which tissue culture flasks 
were seeded it proved possible to alter the kinetics of 
apoptosis induction and, hence, PS externalization. In this 
instance confluent cultures were exposed to doxorubicin 
(15 and 62 ng ml-  1) for periods of 18 and 40 h. Cells were 
harvested, stained with FITC-Annexin V and analysed for 
© 1997 ISHAM, Journal of Medical & Veterinary Mycology 35, 219-224 
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Fig. 3 FITC-Annexin V fluorescence of
HEp-2 cells treated with doxorubicin. 
Confluent cultures of HEp-2 cells were 
exposed to 15 ng ml-1 (Treatment A) or 
62 ng ml 1 (Treatment B) doxorubicin for 
18 or 40 h. Cells were harvested, stained 
with FITC-Annexin V and analysed by 
flow cytometry using a FACScan (Becton 
Dickinson) equipped with Lysis II 
software. Ten thousand cells were analysed 
from each treatment. Log Annexin V binding 
E 
Log Annexin V binding 
PS externalization. Adherence assays were also performed 
using C. albicans ATCC 44990 and HEp-2 cells treated 
with drug for the above periods. 
The result of these experiments indicate some PS 
externalization i cells exposed to doxorubicin for 18 h 
(Fig. 3). HEp-2 cells exposed to either of the doxorubicin 
concentrations demonstrate an increased FITC-Annexin 
V fluorescence compared with that evident for the control 
cells. This result indicates that some apoptosis is occur- 
ring in the population after 18 h incubation in the pres- 
ence of doxorubicin. Incubation of cells for 40 h (Fig. 3) 
produced two clear regions of fluorescence: one associated 
with the control and the other with the cultures exposed 
to doxorubicin, indicating that membrane asymmetry has 
been lost in the drug-treated cultures as a consequence of 
the onset of apoptosis. 
Adherence assays were performed with the HEp-2 cells 
which were treated with doxorubicin for the above time 
periods and cells of C. albicans ATCC 44990. The results 
of these assays (Table 2) indicate that after 18 h exposure 
to the drug, HEp-2 cells exhibit a lower susceptibility to 
Candida adherence than the control cells. Incubation in 
the presence of the drug for 40 h produced a substantial 
drop in adherence (in the case of each drug concen- 
tration adherence has dropped by approximately 50% 
(P < 0-05)). The reduction in susceptibility o yeast adher- 
ence is paralleled by the increased fluorescence associated 
with the Annexin V binding to PS present on the surface 
of the HEp-2 cells treated with doxorubicin (Fig. 3). 
Discussion 
Eukaryotic ell membranes usually restrict particular lipid 
species to one or other side of the bilayer thus creating 
an asymmetric distribution [2t]. The loss of membrane 
© 1997 ISHAM, Journal of Medical & Veterinary Mycology 35, 219-224 
Table 2 Mean number of C. albicans ATCC 44990 adhering to 
HEp-2 cells from confluent cultures exposed to 15 ng ml- 1 or 
62 ng ml- ~ doxorubicin for 18 or 40 h 
Exposure time to doxorubicin 
Doxorubicin conc. 18 h 40 h 
Control 0.97 4- 0.09 0.79 + 0'07 
15 ng ml 1 0"85 4- 0.09 0.38 + 0.06 
62 ng ml- 1 0.67 + 0"08 0.41 4- 0.06 
Confluent cultures of HEp-2 cells were treated with doxorubicin as 
described. After 18 or 40 h, cells were harvested and incubated 
with cells of C. albicans ATCC 44990 in adherence assays. All 
values represent the mean number of yeast adhering per HEp-2 
cell + SE of the mean with 200 HEp-2 cells being counted per 
treatment. Figure 3 indicates the relative levels of FITC-Annexin V 
fluorescence ofHEp-2 cells used in these assays. 
asymmetry as indicated by PS externalization is an early 
indicator of the onset of apoptosis [11] and occurs without 
the loss of membrane integrity [12] and before cell shrink- 
age or nuclear condensation [13]. The aim of the work 
presented here was to establish whether the loss of mem- 
brane asymmetry, as determined by the externalization of
PS, altered the susceptibility of HEp-2 cells to adherence 
by cells of C. albicans. Apoptosis was induced using three 
anticancer drugs and confirmed by the loss of membrane 
asymmetry (Fig. 2) and DNA cleavage. A reduction in the 
susceptibility of HEp-2 cells in the early stages of apop- 
tosis to adherence by C. albieans was evident and this was 
apparent in confluent (Fig. 3 and Table 2) and subcon- 
fluent (Fig. 2 and Table 1) cultures in which apoptosis 
was induced by a number of anticancer agents. Although 
the three drugs used here have different modes of 
action [16-18], all induced apoptosis in HEp-2 cells 
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at the concentrations employed and the resulting cells 
displayed an increased resistance to yeast adherence. 
One of the consequences of the loss of membrane 
asymmetry associated with apoptosis is an alteration in 
the nature of the surface to which the yeast cells adhere 
[10]. In apoptotic lymphocytes the membrane lipids are 
more loosely packed than normal cells, indicating an 
alteration in the outer leaflet of the plasma membrane 
[15]. PS is a negatively charged phospholipid which is 
normally located on the leaflet of the plasma membrane 
facing the cytosol [10]. The appearance of this phospho- 
lipid on the outer leaflet of cell membranes, as a result of 
the loss of membrane asymmetry, alters the surface charge 
and hydrophobicity of these surfaces [10,15] and such 
alterations could affect the non-specific adherence mech- 
anisms of C. albicans [5,6]. The loss of membrane asym- 
metry also disrupts the normal configuration of the outer 
leaflet [10,13]. It is possible that ligands to which yeast 
cells normally bind may be 'hidden' or lost from the 
cell surface as a consequence of the loss of membrane 
asymmetry. 
Although cancer patients receiving chemotherapy dis- 
play an increased susceptibility to fungal infections, the 
work presented here indicates that HEp-2 cells induced to 
die by apoptosis using such drugs manifest an increased 
resistance to adherence by C. albicans. As adherence to 
host tissue is critical to the success of C. albicans as a 
pathogen [1,3,4], the increased resistance of apoptotic 
cells to adherence would appear to hinder fungal attach- 
ment to, and subsequent colonization of, host tissue. In 
addition to targeting neoplastic tissue, chemotherapeutic 
agents may also suppress the immune system which is a 
major factor in the increased incidence of fungal infec- 
tions in such patients [22]. In the host, chemotherapeutic 
agents would appear to manifest a dual effect: cells 
induced to die by apoptosis using such drugs display an 
increased resistance to adherence by C. albicans while the 
host is more susceptible to invasive fungal diseases as a 
result of immunosuppression [23]. 
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